Abstract: A wound debridement system includes a wound dressing having an active layer (40) and a wound interface layer (10). The active layer is formed from one or more pneumatic members (45). The pneumatic members are arranged about a film layer (60), by which the pneumatic members are attached to the wound interface layer. A control unit (80) controls a drive unit (70) to intermittently apply pressure to the pneumatic members of the active layer. The pressure applied by the drive unit causes the pneumatic members to expand and contract. This movement of the pneumatic members is transferred to the wound interface layer, causing the wound interface layer to move relative to a tissue site to which the wound dressing is applied. The wound interface layer may be formed having an abrasive wound-facing surface, such that the movement of the wound interface layer causes a mechanical disruption and debridement of debris at the tissue site.

Abstract: A wound therapy system includes a canister configured to contain fluid removed from a wound site, a primary conduit having a first end coupled to the canister and a second end coupled to the wound site, and a pump fluidly coupled to the wound site via the primary conduit. The pump is configured to apply negative pressure to the wound site via the primary conduit. The system includes a pressure indicator configured to indicate a negative pressure at the pressure indicator and a secondary conduit having a first end coupled to the pressure indicator and a second end coupled to the wound site such that the negative pressure at the wound site is fluidly transmitted to the pressure indicator via the secondary conduit. A blockage in the primary conduit causes the negative pressure indicated by the pressure indicator to differ from the negative pressure applied by the pump.

Abstract: A canister for a wound therapy includes a canister body and a plurality of superabsorbent projections. The canister body is configured to contain wound exudate collected from a wound side. The plurality of superabsorbent projections are fixed to and extend from at least a portion of an interior surface of the canister, and may be formed in a plurality of shapes or patterns comprising circles, squares, hoops/halos, a range of lines, or any combination of said shapes.

Abstract: A wound dressing includes an inelastic absorbent layer, an elastic film, and a plurality of welds. The inelastic absorbent layer is configured to absorb wound fluid and has a first side and a second, wound-facing side. The elastic film is configured to elastically stretch when a stretching force is applied to the wound dressing and elastically recover when the stretching force is removed. The plurality of welds fix the elastic film to the first side of the inelastic absorbent layer such that the elastic film and the inelastic absorbent layer elastically stretch and elastically recover as a unit.

Abstract: A combined instillation fluid delivery pump head and wound fluid collection canister apparatus for use with a negative pressure wound therapy (NPWT) unit includes a body defining a wound fluid collection canister configured to collect wound exudate and defining a pump head formed by a partially cylindrical recess in a wall of the body. The apparatus includes a flexible fluid instillation conduit extending along the pump head to be compressed by a pump rotor from the NPWT unit. The apparatus includes a first conduit fluidly coupled on one end of the first conduit to a negative pressure source on the NPWT unit. The apparatus includes a second conduit having one end of the second conduit communicating with the wound fluid collection canister. The apparatus includes a third conduit fluidly coupled to one end of the flexible fluid instillation conduit.

Abstract: A wound dressing includes a superabsorbent pad, a drape layer, a humidity chamber, a wick, and a humidity colorimeter sensor. The superabsorbent pad is configured to absorb wound fluid and has a first side and a second, wound-facing side. The drape layer is coupled to the first side of the superabsorbent pad and has a first side and a second, wound-facing side. The drape layer is substantially impermeable to liquid and substantially permeable to vapor. The humidity chamber is coupled to the first side of the drape layer opposite the superabsorbent pad. The wick extends through the drape layer and is configured to wick moisture between the superabsorbent pad and the humidity chamber. The humidity colorimeter sensor is located within the humidity chamber and configured to change color responsive to a humidity level within the humidity chamber.

Abstract: A negative pressure wound therapy system includes a wound dressing, at least one pump fluidly coupled to the fluid interface, a pressure sensor fluidly coupled to the wound dressing, a control housing, and an electrical coupler. The wound dressing includes a sealing layer, an absorbent layer adjacent to the sealing layer, and a fluid interface attached to at least one of the sealing layer or the absorbent layer. The at least one pump is configured to apply negative pressure to the fluid interface to draw fluid from the wound dressing via the fluid interface. The pressure sensor is configured to detect a fluid pressure of the wound dressing. The control housing is remote from the wound dressing. The electrical coupler is configured to removably connect the control housing to the at least one pump.

Abstract: A negative pressure wound therapy device includes at least one piezoelectric pump and a control circuit. The control circuit is configured to generate a first control signal to control operation of the at least one piezoelectric pump, the control signal having a first root mean square (RMS) voltage, transmit the first control signal to the at least one piezoelectric pump, identify at least one of a change of state of the at least one piezoelectric pump or an expiration of a duration of time associated with operation of the at least one piezoelectric pump, responsive to identifying the at least one of the change of state or the expiration of the duration of time, generate a second control signal having a second RMS voltage less than the first RMS voltage, and transmit the second control signal to the at least one piezoelectric pump.

Abstract: A negative pressure wound therapy device includes a piezoelectric pump, a state detector configured to detect a state of the pump, and a control circuit configured to transmit a first control signal for a first period having a first RMS voltage greater than or equal to a threshold voltage at which driving the pump for a second period greater than the first period can cause the pump to emit sound at a magnitude greater than a sound threshold; receive a first indication of the state; determine if the pump is in a leak condition; transmit, responsive to the pump not being in the leak condition, a second control signal having a second RMS voltage less than the first RMS voltage; and transmit, responsive to the pump being in the leak condition, a third control signal having a third RMS voltage greater than the second RMS voltage.

Abstract: A dressing includes a foam layer, a plurality of cores extending substantially through the foam layer, and a drape sealable over the foam layer and a wound bed. The drape is couplable to a pump operable to create a negative pressure in the substantially-airtight volume. Each core is substantially removable from the foam layer to reveal a channel through the foam layer. Each core is defined by perforations that facilitate separation of the core from the foam layer.

Abstract: A negative pressure wound therapy (NPWT) device includes a canister, a pump, a filter, and a control unit. The canister is configured to collect wound exudate from a wound site. The pump is fluidly coupled to the canister and configured to draw a vacuum within the canister by pumping air out of the canister. The filter is positioned between the canister and the pump such that the air pumped out of the canister passes through the filter in a first direction. The control unit is configured to operate the pump and to purge the filter by causing airflow through the filter in a second direction, opposite the first direction.

Abstract: A wound therapy system includes a first sensor assembly, a second sensor assembly, and a processing circuit. The first sensor assembly is configured to be located at a wound treatment site on a patients body and to record physical characteristics representative of periwound tissue at the wound treatment site. The second sensor assembly is configured to be located at a healthy tissue site on the patients body contralateral to the wound treatment site and to record one or more physical characteristics representative of healthy tissue at the healthy tissue site. The physical characteristics representative of the healthy tissue are recorded concurrently with the physical characteristics representative of the periwound tissue.

Abstract: Wound therapy dressings are provided. The wound therapy dressings may include at least one selectively transparent layer with a refractive index in a range wherein interaction between the selectively transparent layer and fluids from a treatment site switches the selectively transparent layer from a first, opaque state to a second, transparent state. Dressings that include multiple layers may include polymer films with a plurality of fluid restrictions, a manifold, a transparent polymer drape, and a hydrophobic polymer layer. The dressings may further include negative pressure therapy treatment input devices. A method of use wherein the dressings are used to monitor fluid flow, exudate, and maceration around a treatment site is also provided.

Abstract: A negative pressure wound therapy system includes a dressing, a tube, a flow restriction pad, and an in-line filter. The dressing is configured for placement in a wound bed. The tube includes a first end and a second end. The first end is configured to be operably coupled to the dressing. The second end is configured to engage a negative pressure source. The flow restriction pad is configured to be coupled to the dressing proximate the first end of the tube. The flow restriction pad includes a tortuous fluid flow path that is configured to restrict or reduce an amount of a fluid drawn from the dressing into the tube and induce a backpressure between the dressing and the tube. The in-line filter is positioned within the tube between the first end and the second end. The in-line filter configured to substantially prevent the fluid entering the tube.

Abstract: A partially transparent dressing includes a fluid management core having a first side and a second, wound-facing side. The fluid management core includes an absorbent material and a plurality of optically transparent windows. The dressing includes a barrier layer coupled to the first side and a patient interface layer coupled to the second side. A fluid communication port is disposed in the second side. An opening is disposed in the patient interface layer. The opening is configured to receive fluid from a wound.

Abstract: A canister for a wound therapy includes a canister body and a plurality of superabsorbent projections. The canister body is configured to contain wound exudate collected from a wound side. The plurality of superabsorbent projections are fixed to and extend from at least a portion of an interior surface of the canister, and may be formed in a plurality of shapes or patterns comprising circles, squares, hoops/halos, a range of lines, or any combination of said shapes.

Abstract: A selectively transparent wound therapy dressing, system, and method of use are provided. The dressing may include conformable foam and drape layers, wherein the drape layer has a refractive index substantially within a range of a disclosing liquid. When the disclosing liquid is applied to the drape layer, the drape layer may switch from opaque to transparent. Subsequent evaporation of the disclosing liquid may return the drape layer to an opaque state. Some embodiments provide for paired use with a negative pressure source input device. The method of use provides selective visibility of a treatment site, and reduces the amount of time in which a patient views an acute or traumatic wound or injury.

Abstract: Dressings which may be useful in disrupting and/or preventing biofilm formation in a wound upon application are described, where the dressings of the present technology include a co-polymer of polyvinylpyrrolidone (PVP) and citric acid. Also disclosed herein methods employing such dressings as well as kits including such dressings.

Abstract: An indicator reversibly changes between a first state representative of a first fluid status of a wound dressing, to a second state representative of a second fluid status in response to changes in the fluid status of the wound dressing over time. The fluid status may be a fluid level or a fluid absorbency capacity of the wound dressing. The indicator includes an indicator layer on which one or more markings are provided. A top layer of the indicator transitions from being opaque in the first state to being transparent in the second state. The change from the markings being blocked from view in the first state to being visible in the second state occurs in response to a presence of a first amount of fluid in the wound dressing. The transition from the second state to the first state occurs when evaporation decreases the fluid in the wound dressing.

Abstract: A method for detecting a state of a dressing includes measuring air pressure within a tube. The tube provides airflow between a pump device and the dressing. The method also includes determining whether the air pressure differs from a pressure setpoint by more than a preset limit, and running the pump to cause the air pressure to approach the pressure setpoint. In response to a determination that the air pressure does not differ from the pressure setpoint by more than the preset limit, the method also includes determining a duration of time since a last running of the pump, determining whether the duration of time since the last running of the pump exceeds a threshold duration, and, in response to a determination that the duration of time since the last running of the pump exceeds the threshold duration, generating an alert that indicates that the dressing is full.